剂量免疫检查点抑制剂:未来的机遇
Won Jin Jeon1, So Young Son2, Faith Abodunrin3
1Division of Hematology & Oncology, Loma Linda University, Loma Linda, CA, USA.
Current problems in cancer
|May 8, 2025
概括
免疫检查点抑制剂提供了新的癌症治疗方法,但具有适度的益处和高成本. 需要个性化剂量和生物标志物开发等策略,以改善更多患者的获取和有效性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫疗法的近期进展导致了用于癌症治疗的免疫检查点抑制剂 (ICI).
- 尽管取得了突破,但ICI提供了适度的生存益处,并带有毒性和耐药性的风险.
- 目前的剂量和间隔限制了患者的访问,特别是在资源有限的环境中.
研究的目的:
- 审查目前关于ICI的基于模型和临床研究的文献.
- 讨论加强ICI获取和利用的战略.
- 解决当前ICI剂量的局限性,并确定实践变革的领域.
主要方法:
- 对免疫检查点抑制剂的现有基于模型和临床研究的审查.
- 分析当前的剂量策略,包括固定剂量与基于体重的剂量.
- 探索生物标志物开发和替代临床试验设计.
主要成果:
- 适度的生存益处和ICI增加毒性的可能性.
- 由于高成本和固定的剂量计划,存在重大进入障碍.
- 支持个性化方法的证据,包括剂量调整和生物标志物.
结论:
- 优化ICI剂量和间隔对于改善患者获取和治疗结果至关重要.
- 个性化医疗策略,包括生物标志物,可以提高ICI的疗效,降低毒性.
- 需要进一步的研究和替代试验设计,以在全球范围内扩大ICI的使用.
相关概念视频
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
01:30Cancer Vaccines
251
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
251
01:27Cytotoxic T Cells-mediated Immune Response
731
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
731
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K